Drug
Rosuvastatin 40mg
Rosuvastatin 40mg is a pharmaceutical drug with 4 clinical trials. Currently 1 active trials ongoing. Historical success rate of 100.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
100.0%
Based on 1 completed trials
Completion Rate
100%(1/1)
Active Trials
1(25%)
Results Posted
0%(0 trials)
Phase Distribution
Ph phase_3
1
25%
Ph not_applicable
3
75%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution4 total trials
Phase 3Large-scale testing
1(25.0%)
N/ANon-phased studies
3(75.0%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
100.0%
1 of 1 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
1
trials recruiting
Total Trials
4
all time
Status Distribution
Active(1)
Completed(1)
Other(2)
Detailed Status
unknown2
Recruiting1
Completed1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
1
Success Rate
100.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (25.0%)
N/A3 (75.0%)
Trials by Status
recruiting125%
unknown250%
completed125%
Recent Activity
1 active trials
Showing 4 of 4
recruitingnot_applicable
Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT
NCT06603363
unknownnot_applicable
Effect of Statin Preloading in STEMI in Improving PCI Outcomes
NCT04974814
unknownphase_3
Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study)
NCT04737408
completednot_applicable
Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Plaque Composition in Patients With ST-Segment Elevation Myocardial Infarction (MI)
NCT01058915
Clinical Trials (4)
Showing 4 of 4 trials
NCT06603363Not Applicable
Changes in Plaque Characteristics After Short-term Statin Therapy as Assessed With Coronary CT
NCT04974814Not Applicable
Effect of Statin Preloading in STEMI in Improving PCI Outcomes
NCT04737408Phase 3
Influence of Intensive Lipid-lowering on FFRCT (The FLOW-PROMOTE Study)
NCT01058915Not Applicable
Influence of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Plaque Composition in Patients With ST-Segment Elevation Myocardial Infarction (MI)
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4